Location: Dunblane Hydro Hotel
Date: Friday 28 August 2015
We are grateful for the support of our industry partners-
Other Industry Sponsors
- Zimmer Biomet
[table id=1 /]
We are pleased to announce the introduction of a new feature this year. At 1200 you will have the opportunity to choose which Industry led session you wish to attend:
1. DePuy Synthes
Chaired by: Mr John Davidson (Liverpool)
We know that total knee replacement (TKR) is a very successful procedure, but we also know that there is room for improvement. Join Attune Design Surgeon Mr John Davidson (Liverpool) as he talks through the problem of unmet patient needs and the rationale/process of developing a new knee from DePuy Synthes. Mr Davidson will talk through key areas addressed by the Attune Knee System, including improving motion and stability throughout the flexion curve through improved femoral curvature design, surgical flow and instrumentation, his early results and experiences and the potential for Attune to deliver an optimised commercial solution for total knee arthroplasty
Title: Triathlon Total Knee 10 years of Proven Performance
Chairman: Doug Whitely
Description: By the end of this session the participant will be able to:
- Understand the history of Knee implant design and how it has guided us to present day
- Further understand the role of Joint line and Posterior Condylar Offset
- How Triathlon Total Knee design can improve Pt outcomes
- Complete a dry bone workshop of a Primary Triathlon Knee using the precsion saw.
This session is aimed to be interactive with participants getting hands on experience with the Triathlon Total Knee System.
3. Smith and Nephew
Title: Driving predictable outcomes through implant choice and incision management. A health economic overview
Chaired by : Prof Ed Davis, Consultant Orthopaedic Surgeon, Royal Orthopaedic Hospital, Birmingham
With an increasing focus on clinical effectiveness both in the short and longer term, the choice of implant, bearing and incision management play a key role in reducing the risk of revision, and surgical site infection following total joint arthroplasty. There can be severe clinical and financial consequences to patients and hospitals where length of stay and risk of revision are not managed effectively. This meeting is designed to investigate the evidence and options open to clinicians and financial stakeholders to reduce the increasing cost burden, and review the health economic impact of these choices.
[wpfilebase tag=file id=18 /]